TB Advocates Raise Questions On R&D Targets, Funding For National Action Plan

Center for Global Health Policy’s “Science Speaks”: MDR-TB national action plan raises questions on targets and funding
Rabita Aziz, policy research coordinator for the Center for Global Health Policy, reports on a USAID event launching the White House’s National Action Plan for Combating Multidrug-Resistant Tuberculosis. At the event, Aziz notes TB advocates raised questions about the ambition of and funding for the plan, and event panelists discussed the plan’s lack of specific research and development targets, as well as the need to develop new drugs (1/11).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.